Trubrexa .00025 g/g
lidocaine and capsaicin · PATCH · Asclemed USA, Inc.
No Recall HistoryCurrently in Shortage
Plain English
Trubrexa is a patch containing lidocaine and capsaicin at .00025 g/g, taken transdermal. Manufactured by Asclemed USA, Inc..
Key Facts
- Brand Name
- Trubrexa
- Generic Name
- lidocaine and capsaicin
- NDC Code (Product)
76420-644- Manufacturer
- Asclemed USA, Inc.
- Strength
- .00025 g/g
- Dosage Form
- PATCH
- Route
- TRANSDERMAL
- Marketing Status
- Drug Class
- Amide Local Anesthetic [EPC]; Antiarrhythmic [EPC]
- Marketing Start
- 10/03/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Trubrexa used for?
Trubrexa contains lidocaine and capsaicin. It is a patch taken transdermal. Consult your doctor for specific uses.
Is Trubrexa a controlled substance?
Trubrexa is not classified as a controlled substance by the DEA.
What is the generic name for Trubrexa?
The generic name for Trubrexa is lidocaine and capsaicin. There are no other listed brand versions of lidocaine and capsaicin.
What is the NDC code for Trubrexa .00025 g/g?
The NDC (National Drug Code) for Trubrexa .00025 g/g is 76420-644, listed by Asclemed USA, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)